1. Home
  2. CRGO vs FLNA Comparison

CRGO vs FLNA Comparison

Compare CRGO & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$1.23

Market Cap

66.7M

Sector

Finance

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.89

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRGO
FLNA
Founded
2012
1998
Country
Spain
United States
Employees
382
20
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
61.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CRGO
FLNA
Price
$1.23
$0.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.40
N/A
AVG Volume (30 Days)
55.8K
368.3K
Earning Date
05-26-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.61
N/A
Revenue Next Year
$16.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$0.90
52 Week High
$4.24
$2.03

Technical Indicators

Market Signals
Indicator
CRGO
FLNA
Relative Strength Index (RSI) 42.22 23.58
Support Level $1.17 N/A
Resistance Level $1.45 $1.80
Average True Range (ATR) 0.10 0.07
MACD 0.02 -0.02
Stochastic Oscillator 26.11 2.43

Price Performance

Historical Comparison
CRGO
FLNA

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: